MOUKOVÁ, Lucie, Vladimíra VALLOVÁ, Iva SLÁMOVÁ, Miroslava KIŠŠOVÁ and Petr KUGLÍK. Initial experience with determination of hTERC and MYCC genes amplification in cervical intraepithelial neoplasia and cervical carcinoma in the Czech Republic. European Oncology and Haematology. Touch Briefing, London, 2012, vol. 8, No 2, p. 92-96. ISSN 1758-3853.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Initial experience with determination of hTERC and MYCC genes amplification in cervical intraepithelial neoplasia and cervical carcinoma in the Czech Republic
Authors MOUKOVÁ, Lucie, Vladimíra VALLOVÁ, Iva SLÁMOVÁ, Miroslava KIŠŠOVÁ and Petr KUGLÍK.
Edition European Oncology and Haematology, Touch Briefing, London, 2012, 1758-3853.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Science
Keywords (in Czech) cervical carcinoma; cervical intraepithelial neoplasia (CIN); hTERC gene amplification, MYCC gene amplification; fluorescence in situ hybridization; genetic abnormalities
Keywords in English karcinom děložmího hrdla; cervikální intraepiteliální neoplázie; amplifikace genu hTERC; fluorescenční hybridizace in situ; genetické abnormality
Changed by Changed by: doc. RNDr. Petr Kuglík, CSc., učo 1881. Changed: 17/3/2016 10:39.
Abstract
Tumors are frequently characterized by series of cytogenetic abnormalities. Amplifications of hTERC (3q26) and MYCC (8q24) genes have been associated with cervical intraepithelial neoplasia (CIN) and carcinoma of uterine cervix. The results of genetic analysis could select patients with high risk of progression from CIN to carcinoma. In this study, chromosomal abnormalities in cytology specimens of cervical carcinoma or CIN of 26 patients were analyzed using new developed triple-colour HPV-FISH assay. HPV infection was proven in 85 % (22/26) of patients. Amplification of hTERC and MYCC gene was found in 46 % (12/26) and 62 % (16/26) of patients, respectively. Based on these results we were able to divide patients into high-risk, medium-risk and low-risk group. We confirmed that HPV-FISH assay can be used as an effective diagnostic procedure to identify patients carrying highly risking HPV infection and chromosomal aberrations associated with this malignancy. Patients of the high-risk group would benefit from intensive dispensarisation and aggressive therapy in the future. Tumors are frequently characterized by series of cytogenetic abnormalities. Amplifications of hTERC (3q26) and MYCC (8q24) genes have been associated with cervical intraepithelial neoplasia (CIN) and carcinoma of uterine cervix. The results of genetic analysis could select patients with high risk of progression from CIN to carcinoma. In this study, chromosomal abnormalities in cytology specimens of cervical carcinoma or CIN of 26 patients were analyzed using new developed triple-colour HPV-FISH assay. HPV infection was proven in 85 % (22/26) of patients. Amplification of hTERC and MYCC gene was found in 46 % (12/26) and 62 % (16/26) of patients, respectively. Based on these results we were able to divide patients into high-risk, medium-risk and low-risk group. We confirmed that HPV-FISH assay can be used as an effective diagnostic procedure to identify patients carrying highly risking HPV infection and chromosomal aberrations associated with this malignancy. Patients of the high-risk group would benefit from intensive dispensarisation and aggressive therapy in the future.
Links
NT11089, research and development projectName: Diagnostický význam amplifikace genů hTERC a MYCC při vzniku a vývoji cervikálních intraepiteliálních dysplázií a karcinomu děložního hrdla
PrintDisplayed: 4/5/2024 12:44